AROPEM 0.5g Price

Overview

Welcome to Dwaey, specifically on AROPEM 0.5g Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Meropenem (as trihydrate).
AROPEM 0.5g is available in the market in concentration 500mg/Vial and in the form of Injection/Powder for.

ARWAN PHARMACEUTICAL INDUSTRIES LEBANON s.a.l. is the producer of AROPEM 0.5g and it is imported from LEBANON, The most popular alternatives of AROPEM 0.5g are listed downward .

Mode Of Action

Meropenem is a synthetic carbapenem beta-lactam antibiotic that exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in gm+ve and gm-ve bacteria through binding to several penicillin-binding proteins (PBPs).

Indication

• Cystic fibrosis
• Intra-abdominal infections
• Meningitis
• Skin and skin structure infections
• Diabetic foot infection

Precaution

Patient w/ underlying CNS disorders (e.g. brain lesions, history of seizures. Not recommended for treatment of MRSA. Renal impairment. Childn. Pregnancy and lactation. Monitoring Parameters Monitor for signs of anaphylaxis during 1st dose. Periodically assess renal, hepatic, and haematopoietic functions during prolonged therapy. Lactation: Unknown whether drug is excreted in breast milk; use with caution

Side Effects

• 1-10% Constipation (1-7%)
• Diarrhea (4-5%)
• Nausea or vomiting (1-4%)
• Rash (2-3%; includes diaper-area moniliasis in pediatric patients)
• Headache (2%)
• Inflammation at injection site (2%)
• Sepsis (2%)
• Oral moniliasis (?2% in pediatric patients)
• Bleeding (1.2%)
• Apnea (1%)
• Constipation (1%)
• Glossitis (1%)
• Injection-site reaction (1%)
• Phlebitis or thrombophlebitis (1%)
• Pruritus (1%)
• Septic shock (1%) <1% Agranulocytosis
• Angioedema
• Erythema multiforme
• Hypersensitivity reaction
• Hypokalemia
• Leukopenia
• Neutropenia
• Pleural effusion
• Stevens-Johnson syndrome
• Toxic epidermal necrolysis disorders or renal impairment. Potentially Fatal: Anaphylaxis; pseudomembranous colitis; Stevens-Johnsons sydrome.

Contra indication

Hypersensitivity to meropenem, other carbapenems. History of anaphylactic reaction to ?-lactams (e.g. penicillins, cephalosporins).

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.